Benzylic Acid

Benzylic Acid

SCHEMBL6434928

C1CCNC1.O=C(O)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.55
CYP2D6 P10635 4/20 0.46
LMNA P02545 3/20 0.46
MEN1 O00255 1/20 0.46
HRH1 P35367 1/20 0.46
SCN1A P35498 1/20 0.46
KMT2A Q03164 1/20 0.46
SCN2A Q99250 1/20 0.46
SCN3A Q9NY46 1/20 0.46
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
HIF1A Q16665 1/20 0.43
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
CHRM2 P08172 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzylic Acid SCHEMBL27825208 0.98 CYP2C9 (0.53) CYP2C9CYP2D6LMNAMEN1HRH1
Benzylic Acid SCHEMBL7066 0.83 CYP2C9 (0.74) CYP2C9CYP2D6LMNAKMT2AKEAP1
Benzylic Acid SCHEMBL9568239 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL1681667 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL868225 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL9181980 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL5705762 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL11049826 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL20957595 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A
Benzylic Acid SCHEMBL1680669 0.81 CYP2C9 (0.71) CYP2C9CYP2D6LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1589959-A2 METHODS OF TREATING LOWER URINARY TRACT DISORDERS USING SODIUM CHANNEL MODULATORS Dynogen Pharmaceuticals Inc. (US) 2005-11-02 EP disclosed
WO-2004066990-A2 METHODS OF TREATING LOWER URINARY TRACT DISORDERS USING SODIUM CHANNEL MODULATORS DYNOGEN PHARMACEUTICALS, INC. (US) 2004-08-12 WO disclosed